Jack Hough

The discount chain doesn’t get the respect of its bigger rival, but there’s much for a shopper to love. And here’s why Wall Street should love it, too.

Coca-Cola stock has raced ahead of PepsiCo this year. It all has to do with the mysteries of taste.

This blockbuster class of drugs is shattering all sales records. Which stock will do better—Eli Lilly or Novo Nordisk?

Second-quarter earnings growth is up by 25%, and could go even higher. Why aren’t stocks keeping up?

The S&P 500 is suddenly lagging behind other indexes, bringing rewards for investors who stuck with international, small-caps, and other parts of the stock market.

Perpetual futures contracts are complicated—and are often used with extreme leverage. You’re right to be wary.

It once was as hot as Amazon and Apple. Now it’s one of the 10 worst-performing stocks in the S&P 500.

From Delta’s Bastian to Exxon Mobil’s Woods, these 25 leaders have positioned their companies for long-term success.

Under Bastian, employees get a generous cut of pretax profits. The move pays for itself in enhanced customer satisfaction.

Nvidia’s co-founder and CEO has ensured that the company dominates in AI chips.

Pichai oversaw a smooth transition from search dominance to AI mastery—and a doubling in the share price in the past year.

Ricks has led a $50 billion manufacturing Marshall Plan in pharma to safeguard Lilly’s lead in obesity and diabetes treatments.

CEO Raj Subramaniam has broken down the delivery company’s business silos and elevated its stock price.

Tan’s tech juggernaut has been a gold mine for investors; the stock has returned 34,000% during his tenure.

Corning is an Innovator in glass. Weeks has retooled it for the AI era.

The march of trillicorn initial public offerings doesn’t portend doom for investors. But it’s worth keeping an eye on just the same.

Eli Lilly and Natera are among the companies that can keep growing after the artificial-intelligence hype fades. Plus, Five Below’s “squishy dumpling” score.

Sales for AutoZone have expanded from $12.6 billion in the fiscal year ended in August 2020 to an estimated $20.5 billion this fiscal year.

The stock’s bulls say margins will revert to normal once the sneaker maker regains its footing. But what if it just keeps stumbling?

After this fiscal year, Take-Two is expected to triple its earnings per share in four years. It reports fourth-quarter earnings late Thursday.